855675P

16:0 Lyso PC

Avanti Research^™ - A Croda Brand

• 别名: 1-十六烷酰基-sn-甘油-3-磷酸胆碱；PC(16:0/0:0)
• 经验公式（希尔记法）: C₂₄H₅₀NO₇P
• CAS号: 17364-16-8
• 分子量: 495.63
• 分類程式碼代碼: 51191904
• NACRES: NA.25

属性

• 描述: 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine
• 化驗: >99% (LPC; may contain up to 10% of the 2-LPC isomer, TLC)
• 形狀: powder
• 包裝: pkg of 1 × 1 g (855675P-1g); pkg of 1 × 200 mg (855675P-200mg); pkg of 1 × 25 mg (855675P-25mg); pkg of 1 × 500 mg (855675P-500mg)
• 製造商／商標名: Avanti Research^™ - A Croda Brand
• 運輸包裝: dry ice
• 儲存溫度: −20°C
• SMILES 字串: O[C@](COP([O-])(OCC[N+](C)(C)C)=O)([H])COC(CCCCCCCCCCCCCCC)=O
• InChI: 1S/C24H50NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-24(27)30-21-23(26)22-32-33(28,29)31-20-19-25(2,3)4/h23,26H,5-22H2,1-4H3/t23-/m1/s1
• InChI 密鑰: ASWBNKHCZGQVJV-HSZRJFAPSA-N

说明

應用

• Microbubble-Mediated Drug Delivery: The role of 16:0 Lyso PC in the development of microbubble technologies for drug delivery systems emphasizes its potential in pharmaceutical formulations, enhancing the efficiency of targeted therapy applications, particularly in cancer treatment (Aron et al., 2019).


• Photodynamic Therapy for Glioma: Research involving 16:0 Lyso PC in the context of biohybrid systems for light-activatable treatments showcases its application in medical therapies, particularly for treating challenging conditions like glioma through photodynamic therapy, underlining its potential in enhancing clinical outcomes (Inglut et al., 2019).

包裝

20 mL 透明玻璃螺纹口小瓶(855675P-1g)

20 mL 透明玻璃螺纹口小瓶(855675P-500mg)

5 mL 棕色玻璃螺纹口样品瓶（855675P-200mg）

5 mL 棕色玻璃螺纹口样品瓶（855675P-25mg）

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全信息

• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable